Supplementary Figure S1 from Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II Trial
Authors:
- Thomas E. MürdterTMThomas E. Mürdter
- Werner SchrothWerner Schroth
- Matthew P. GoetzMGMatthew P. Goetz
- Roman TremmelRoman Tremmel
- Svitlana IgelSISvitlana Igel
- Elke SchaeffelerESElke Schaeffeler
- Simon JägerSJSimon Jäger
- Sibylle LoiblSLSibylle Loibl
- Andreas GerteisAGAndreas Gerteis
- Lena PfaffLPLena Pfaff
- Christina BechtnerCBChristina Bechtner
- Denise WrobelDWDenise Wrobel
Open Access
- 1 December 2025
- other
- Published by American Association for Cancer Research (AACR)